Filing Details
- Accession Number:
- 0001493152-24-008916
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 20:00:30
- Reporting Period:
- 2023-08-22
- Accepted Time:
- 2024-03-05 20:00:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1835022 | Coya Therapeutics Inc. | COYA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1953080 | Ann Lee | 5850 San Felipe St., Suite 500 Houston TX 77057 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2023-08-22 | 1,000 | $3.62 | 17,479 | No | 4 | P | Indirect | By Spouse IRA |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Spouse IRA |
Footnotes
- Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request.
Billionaire Hedge Funds
